Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer

British Journal of Cancer

Volumn 71, Issue 3, 1995, Pages 438-441

  Ito, I ^a,b   Yoshimoto, M ^a   Iwase, T ^a   Watanabe, S ^a   Katagiri, T ^a   Harada, Y ^a   Kasumi, F ^a   Yasuda, S ^b   Mitomi, T ^b   Emi, M ^a   Nakamura, Y ^a  

^a CANCER INSTITUTE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Oestrogen receptor; Oss of heterozygosity; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CHROMOSOME 16Q; CHROMOSOME 17; CHROMOSOME 17P; CHROMOSOME 17Q; CONTROLLED STUDY; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C MYC; PRIORITY JOURNAL;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 17; COMPARATIVE STUDY; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DELETION; GENES, ERBB-2; GENES, MYC; HETEROZYGOTE; HUMAN; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SUPPORT, NON-U.S. GOV'T;

EID: 0028950859     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.89     Document Type: Article

References (25)

1. BECK CA AND EDWARDS DP. (1991). Progesterone receptors in breast cancer. In Genes, Oncogenes, and Hormones: Advances in Cellular AND Molecular Biology of Breast Cancer, Dickson RB AND Lippman ME (eds) pp. 317-352. Kluwer Academic Publishers: Boston.
2. BERNS EMJJ, KLUN JGM, VAN STAVEREN IL, PORTENGEN H, NOORDEGRAAF E AND FOEKENS JA. (1992). Prevalence of amplification of the oncogenes c-myc, HER2 neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. Eur. J, Cancer, 213, 697-700.
3. BUFTON L, MOHANDAS TK, MAGENIS RE, SHEEHY R, BESTWICK RK AND LITT M. (1986). A highly polymorphic locus on chromosome 16q revealed by a probe from a chromosome-specific cosmid library. Hum. Genet., 74, 425-431.
4. BORG A, BALDETORP B, FERNO M, KILLANDER D, OLSSON H AND IGURDSSON H. (1991). ERBB2 amplification in breast cancer with a high rate of proliferation. Oncogene, 6, 137-143.
5. BRAGG T, NAKAMURA Y, GILL J, O'CONNELL P, LEPPERT M, LATHROP GM, LALOUEL J-M AND WHITE R. (1987). Isolation AND mapping of a polymorphic DNA sequence pTBAB5.7 on chromosome 2 (D2S47). Nucleic. Acids Res., 15, 10072.
6. CALLAHAN R AND CAMPBELL G. (1989). Mutations in human breast cancer: an overview. J, Natl Cancer Inst., 81, 1780-1786.
7. CORNELIS RS, DEVILEE P, VAN VLIET M, KUIPERS-DUKSHOORN N, KERSEMAEKER A, BARDOEL A, KHAN PM AND CORNELISSE CJ. (1993). Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions. Oncogene, 8, 781-785.
8. EMI M, TAKAHASHI E, KOYAMA K, OKUI K, OSHIMURA M AND NAKAMURA Y. (1992). Isolation AND mapping of 88 new RFLP markers on human chromosome 8. Genomics, 13, 1261-1266.
9. FEINBERG AP AND VOGELSTEIN B. (1984). A technique for radiolabeling DNA restriction endonuclease fragments for high specific activity. Anal. Biochem., 137, 266-267.
10. FUJIWARA Y, MONDEN M, MORI T, NAKAMURA Y AND EMI M. (1993). Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res., 53, 857-860.
11. HENDERSON BE, ROSS R AND BERNSTEIN L. (1988). Estrogens as a cause of human cancer The Richard & Hilda Rosenthal Foundation Award Lecture. Cancer Res., 48, 246-253.
12. HORWTTZ KB. (1993). Mechanisms of hormone resistance in breast cancer. Breast Cancer Res., 26, 119-130.
13. INAZAWA J, SAITO H, ARIYAMA T, ABE T AND NAKAMURA Y. (1993). High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization. Genomics, 16, 153-162.
14. JAPANESE BREAST CANCER SOCIETY. (1989). The general rules for clinical AND pathological recording of breast cancer. Jpn J, Surg., 19, 612-632.
15. KONDOLEON S, VISSING H, LUO XY, MAGENIS RE, KELLOGG J AND LI 11 M. (1987). A hypervariable RFLP on chromosome 17pl3 is defined by an arbitrary single copy probe pl44-D6 [HGM9 No. D17S34]. Nucleic Acids Res., 15, 10605.
16. MARTIN MB, SACEDA M AND LINDSEY RK. (1991). Estrogen AND progesterone receptors. In Regulatory Mechanisms in Breast Cancer, Lippman M AND Dickson R (eds) pp. 273-288. KJuwer Academic Publishers: Boston.
17. NAKAMURA Y, LEPPERT M, O'CONNELL P, WOLFF R, HOLM T, CULVER M, MARTIN C, FUJIMOTO E, HOFF M AND KUMLIN E. (1987). Variable number of tandem repeat (VNTR) markers for human gene mapping. Science, 235, 1616-1622.
18. NAKAMURA Y, FUJIMOTO E, O'CONNEL P, LEPPERT M, LATHROP GM, LALOUEL J-M AND WHITE R. (1988). Isolation AND mapping of a polymorphic DNA sequence (pEFD64.2) on chromosome 3 (D3S46). Nucleic Acids Res., 16, 9354.
19. SATO T, TANIGAMI A, YAMAKAWA K, AKIYAMA F, KASUMI F, SAKAMOTO G AND NAKAMURA Y. (1990). Alleloptype of breast cancer cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50, 7184-7189.
20. SATO T, AKIYAMA F, SAKAMOTO G, KASUMI F AND NAKAMURA Y. (1991). Accumulation of genetic alterations AND progression of primary breast cancer. Cancer Res., 51, 5794-5799.
21. SLAMON DJ, CLARK GM, WONG SG, LEVIN WJ, ULLRICH A AND McGUIRE WM. (1987). Human breast cancer: correlation of relapse AND survival with amplification of the HER-2 rieu oncogene. Science, 235, 177-182.
22. THOMPSON AM, STEEL CM, CHETTY U, HAWKINS RA, MILLER WR, CARTER DC, FORREST AP AND EVANS HJ. (1990). P53 gene mRNA expression AND chromosome 17p allele loss in breast cancer. Br. J, Cancer, 61, 74-78.
23. WITTLIF, JL. (1984). Steroid-hormone receptors in breast cancer. Cancer, 53, 630-643.
24. YAMAMOTO T, IKAWA S, AKIYAMA T, SEMBA K, NOMURA N, MIYAJIMA N, SAITO T AND TOYOSHIMA K. (1986). Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature, 319, 230-234.
25. YAMASHITA H, KOBAYASHI S, IWASE H, ITOH Y, KUZUSHIMA T, IWATA H, ITOH K, NAITO A, YAMASHITA T, MASAOKA A AND KIMURA N. (1993). Analysis of oncogenes AND tumor suppressor genes in human breast cancer. Jpn J, Cancer Res., 84, 871-878.